Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,183.2
3.8 (0.12%)

 

  • STI Straits Times Index
    3,183.2
    3.8 (0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,604.0
    5.7 (0.36%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,743.5
    -157.3 (-0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,391.1
    -25.6 (-0.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,713.2
    92.2 (0.31%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,050.3
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 299.9M
  • Value: 216.4M
  • Rise: 106
  • Fall: 83
  • Unch: 581

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.199+0.002
P5 Capital0.039+0.001
Jiutian Chemical0.099-0.002
Rex Intl0.182-0.001
Oceanus^0.041-0.001
Anchor Resources0.031-
Genting Sing0.900-0.005
MM2 Asia0.058-0.001
Ntegrator Intl0.015+0.001
GHY Culture0.745-0.010

World Indices

World Indices
Name Last Change
Nasdaq 13,857.8 -138.3
HSI 28,748.2 -152.6
HSCEI 10,913.9 -85.4
Jakarta 6,050.3
Nikkei 225 29,712.3 +91.3
SSE Comp 3,391.2 -25.5
Shanghai A 3,554.5 -26.7
Shanghai B 245.8 -0.1
KOSPI 3,192.8 +10.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ATHIRA PHARMA INC ATHIRA PHARMA INC
Updated on 14 Apr 2021 (End of trading day)
Last (USD): 17.490 Change: +0.590 High: 18.050 Remarks: -
Change (%): +3.49 Low: 16.951
Open 17.030 Yesterday's Close 16.9
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 197,767 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.53758 Trailing EPS (USD) e -0.53758 NAV (USD) b 7.3890
PE a - Trailing PE f - Price / NAV b 2.3670
Dividend (USD) d - Cash In Hand (USD) g 1.6332 Issued & Paid-up Shares c 37,120,400
Dividend Yield (%) d - Price / Cash In Hand g 10.709 Treasury Shares h -
Market Cap (M) 649.236 Enterprise Value (M) 465.554
Piotroski F Score 3 Exchange Code ATHA Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 87.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Mar 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Sep 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ATHIRA PHARMA INC NASDAQ 649.236 - - 2.3670 -
Industry Biotechnology NASDAQ 2,889.243 106.306 106.381 6.6771 0.613
Local Peer AMGEN INC NASDAQ 143,731.695 19.787 19.787 15.2760 2.575
Local Peer GILEAD SCIENCES INC NASDAQ 81,540.774 662.955 662.933 4.4798 4.183
Local Peer MODERNA INC NASDAQ 64,040.805 - - 25.0023 -
Local Peer ILLUMINA INC NASDAQ 58,819.585 89.664 89.664 12.5308 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 55,889.807 20.611 20.611 6.4339 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 51,106.235 14.547 14.547 4.6354 -
Local Peer BIOGEN INC NASDAQ 40,076.235 10.018 10.018 3.7453 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,306.822 56.856 56.856 2.9445 -
Local Peer BIONTECH SE SPON ADS EACH REP 1 ORD SHS NASDAQ 31,310.782 1,807.333 1,807.226 18.6538 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 27,569.966 - - 7.1254 -
Local Peer SEAGEN INC NASDAQ 26,144.325 42.603 42.603 7.4953 -
Local Peer EXACT SCIENCES CORP NASDAQ 21,498.484 - - 7.6142 -
Other Local Peers 10X GENOMICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), FATE THERAPEUTICS (NASDAQ), EXELIXIS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), OLINK HLDG AB SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SEER INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), ARVINAS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ORGANOGENESIS HOLDINGS INC (NASDAQ), INSTIL BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), FIBROGEN INC (NASDAQ), MACROGENICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), BIOATLA INC (NASDAQ), ALLOVIR INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ALECTOR INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), EDGEWISE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), TRANSLATE BIO INC (NASDAQ), OCUGEN INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), NKARTA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AFFIMED N V (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), VOR BIOPHARMA INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CURIS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PERSONALIS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), VANDA PHARMACE INC (NASDAQ), HUMANIGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), EPIZYME INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), IMMATICS N V (NASDAQ), ARDELYX INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), KADMON HLDGS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), IKENA ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AKOUOS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), ALTIMMUNE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), VERASTEM INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ATRECA INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), LAVA THERAPEUTICS NV (NASDAQ), ADICET BIO INC (NASDAQ), SESEN BIO INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ONCORUS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), IMMUNOME INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), KAMADA LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEXTCURE INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), MEDICINOVA INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMV INC (NASDAQ), EVOGENE LTD (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), CHIASMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GAIN THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), LONGEVERON INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), METACRINE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ARAVIVE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), AIKIDO PHARMA INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ADVAXIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), VACCINEX INC (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), HISTOGEN INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), PRECIPIO INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ)
Global Peer CSL LTD ASX 121,881.136 38.861 32.025 11.5338 1.096
Global Peer WUXI BIO HKEx 445,570.147 234.782 234.784 18.2745 -
Global Peer BEIGENE HKEx 214,104.752 - - 7.1365 -
Global Peer SINO BIOPHARM HKEx 151,639.494 48.698 48.698 7.6369 -
Global Peer ZAI LAB-SB HKEx 113,551.218 - - 12.5237 -
Global Peer JOINN HKEx 36,127.468 102.061 102.061 24.8760 0.247
Global Peer Lonza SGX 5,940.891 4.560 4.560 0.5844 5.624
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 3,989.872 13.077 13.077 2.7573 -
Global Peer GENSCRIPT BIO HKEx 29,465.910 - - 4.2144 -
Global Peer NUVATION BIO INC NYSE 2,518.211 - - 17.7074 -
Other Global Peers ARCUS BIOSCIENCES INC (NYSE), 3SBIO (HKEx), VIVA BIOTECH (HKEx), JACOBIO-B (HKEx), JW THERAP-B (HKEx), KINTOR PHARMA-B (HKEx), MYOVANT SCIENCES LTD (NYSE), POLYNOVO LIMITED (ASX), HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), FRONTAGE (HKEx), MESOBLAST LTD (ASX), ASCENTAGE-B (HKEx), JHBP-B (HKEx), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), SINOMAB BIO-B (HKEx), DPHARMA (Bursa), LEE'S PHARM (HKEx), ANTEOTECH LIMITED (ASX), OPTHEA LIMITED (ASX), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), SQZ BIOTECHNOLOGIES CO (NYSE), 22ND CENTURY GROUP INC (NYSE American), NANOVIRICIDES INC (NYSE American), IMMUTEP LTD (ASX), NEXT SCIENCE LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ENZO BIOCHEM INC (NYSE), BIOMX INC (NYSE American), CEL-SCI CORP (NYSE American), BIONOMICS LTD (ASX), IBIO INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), LEAF RESOURCES LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CHIMERIC THERAPEUTICS LTD (ASX), GENETIC TECHNOLOGIES (ASX), CYNATA THERAPEUTICS LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), PATRYS LIMITED (ASX), ORAGENICS INC (NYSE American), Suntar Eco-City (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIOTRON (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), REGENEUS LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), RHINOMED LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CRYOSITE (ASX), NANOLLOSE LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.290
-6.87 %
10 Days --0.910
-4.95 %
20 Days --3.170
-15.34 %
Medium Term Return 3 Months --10.500
-37.51 %
6 Months --0.440
-2.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.790 - 34.790 Change From 1 Year Low +1.700 % Change From 1 Year Low (%) +10.77
Change From 1 Year High -17.300 % Change From 1 Year High (%) -49.73
2 Years Range 15.790 - 34.790 Change From 2 Years Low +1.700 % Change From 2 Years Low (%) +10.77
Change From 2 Years High -17.300 % Change From 2 Years High (%) -49.73
5 Years Range 15.790 - 34.790 Change From 5 Years Low +1.700 % Change From 5 Years Low (%) +10.77
Change From 5 Years High -17.300 % Change From 5 Years High (%) -49.73
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline include ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Seattle, WA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Apr 2021 16.830 17.660 16.800 16.900 164,082 -
12 Apr 2021 18.950 18.950 16.780 16.800 321,136 -
09 Apr 2021 18.600 19.320 18.440 19.080 183,532 -
08 Apr 2021 18.960 19.031 18.580 18.650 133,139 -
07 Apr 2021 18.820 19.120 18.560 18.780 149,396 -
06 Apr 2021 18.870 19.000 18.595 18.800 180,089 -
05 Apr 2021 18.500 19.490 18.500 18.900 244,584 -
01 Apr 2021 18.380 19.000 17.970 18.390 318,412 -
31 Mar 2021 17.170 18.540 16.810 18.400 407,543 -
30 Mar 2021 17.300 17.400 16.330 16.900 305,750 -
29 Mar 2021 18.100 18.410 16.874 17.370 251,535 -
26 Mar 2021 18.150 19.000 17.405 18.090 272,125 -
25 Mar 2021 17.580 18.080 16.950 17.960 260,873 -
24 Mar 2021 18.680 19.000 17.380 17.760 284,314 -
23 Mar 2021 19.225 19.580 18.430 18.520 235,816 -
22 Mar 2021 19.650 19.880 18.800 19.010 218,681 -
19 Mar 2021 19.890 20.670 19.160 19.170 660,022 -
18 Mar 2021 20.380 20.915 19.500 20.100 247,790 -
17 Mar 2021 20.640 21.195 20.400 20.660 302,666 -
16 Mar 2021 20.960 21.740 20.590 20.840 176,272 -
15 Mar 2021 21.155 21.740 20.710 20.930 145,466 -
12 Mar 2021 21.500 21.950 20.740 21.560 271,917 -
Summary
Current 2 Weeks
(30 Mar 2021 to 13 Apr 2021)
17.300 19.490 16.330 16.900 2,407,663 -
Previous 2 Weeks
(16 Mar 2021 to 29 Mar 2021)
20.960 21.740 16.330 17.370 2,910,094 -
4 Weeks from
(16 Feb 2021 to 15 Mar 2021)
21.940 22.080 16.330 20.930 7,882,905 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.